Alternative splicing has been shown to be a key component in metastatic phenotypes [69], and TGFβ-mediated splice variation drives epithelial–mesenchymal transition [50], a commonly misregulated process in carcinomas. The gene discussed is TGFB1; the disease is carcinoma.